Aurinia Pharmaceuticals Inc. reports

Company location: Edmonton, Alberta, Canada
Fiscal year end: 31 December

Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 251-275 of 606 matching filings.

Per page

25

Current page

11

4

FORM 4

Filing date: 14 Sep 2021
Reporting date: 10 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Sep 2021
Reporting date: 10 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Sep 2021
Reporting date: 10 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Sep 2021
Reporting date: 07 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Sep 2021
Reporting date: 07 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Aug 2021
Reporting date: 26 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 26 Aug 2021
Reporting date: 25 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36421

8-K

Filing date: 17 Aug 2021
Reporting date: 17 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 10 Aug 2021
Reporting date: 09 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Aug 2021
Reporting date: 09 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36421

10-Q

Filing date: 05 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36421

8-K

Filing date: 05 Aug 2021
Reporting date: 05 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 29 Jul 2021
Reporting date: 28 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36421

8-K

Filing date: 19 Jul 2021
Reporting date: 16 Jul 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-8 File 333-257424

S-8

Filing date: 25 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36421

8-K

Filing date: 25 Jun 2021
Reporting date: 25 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2021
Reporting date: 22 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 17 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36421

8-K

Filing date: 17 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 14 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .